What is the current price and short-term outlook for NOVN.SW stock?

NOVN.SW stock is at CHF120.84 pre-market on 13 Mar 2026. Heavy volume marks it most-active; a break above CHF126.39 would signal momentum, while a fall below CHF120.36 risks further weakness. Use stop sizing and watch earnings catalysts.

How does Meyka AI evaluate NOVN.SW stock?

Meyka AI rates NOVN.SW with a score of 78.28/100 (B+, BUY). The grade blends benchmark, sector, financial growth and analyst inputs. This is informational and not investment advice; always combine with your own research.

What price targets and risks should investors watch for NOVN.SW stock?

Meyka AI's forecast model projects a quarterly target of CHF137.85 (implied +14.08%) and a one-year projection of CHF117.11 (implied -3.09%). Key risks include pipeline setbacks, FX swings, and near-term earnings surprises.

CH Stocks

CHF120.84 Novartis (NOVN.SW, SIX) pre-market 13 Mar 2026: most-active, outlook

ByDanny Kontos March 13, 2026

NOVN.SW stock opens pre-market at CHF120.84 on 13 Mar 2026 and registers heavy volume, making Novartis AG one of the most-active names on the SIX exchange. The share is trading near its 50-day average of CHF119.83 and sits well above its 200-day average of CHF105.52, signalling continued investor interest. Key metrics show a trailing EPS of CHF5.56 and a PE of 21.73, while volume of 2,679,224.00 shares indicates active intraday flows that could drive short-term moves. We examine valuation, technicals, Meyka AI grading, and a forecast that frames near-term trade ideas.